IP Library Granted Patent US 12,180,538
Granted Patent B2
US 12,180,538 · App. 17/502,526 · Granted Dec 31, 2024

Methods and compositions for capping nucleic acids

Inventors: Hari K. K. Subramanian (San Diego, CA); Chad Fleischer (San Diego, CA); Denis Malyshev (San Diego, CA)
Assignee: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
C12Q1/6811C12Q1/682C12Q1/6827C12Q1/6869C12Q2521/101C12Q2525/203C12Q2525/30C12Q2527/113C12Q2527/137C12Q2533/101C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,180,538
App. No.
17/502,526
Granted
Dec 31, 2024
Kind
B2
Abstract

A method for identifying a nucleic acid template that include (a) providing a plurality of primer-template hybrids, wherein a first hybrid of the plurality includes a first template hybridized to a first primer, and wherein a second hybrid of the plurality includes a second template hybridized to a second primer, the second primer having a ternary complex inhibitor moiety at the 3′ end; (b) delivering polymerases and nucleotides to the plurality, whereby the first hybrid binds a polymerase and nucleotide to form a stabilized ternary complex and whereby the second hybrid does not bind a polymerase and nucleotide to form a stabilized ternary complex; and (c) detecting the stabilized ternary complex to identify the first template.

Claims (31)

1. A method for sequencing two template regions in a nucleic acid, comprising

(a) sequencing a first template region of a nucleic acid in a sequencing process that produces an extended first primer;

(b) capping the extended first primer with a ternary complex inhibitor moiety, thereby forming a capped primer-template hybrid on the nucleic acid;

(c) hybridizing a second primer to a second template region of the nucleic acid to form a nucleic acid comprising the capped primer-template hybrid and a second primer template hybrid; and

(d) performing a sequencing process, comprising:

(i) binding the second hybrid to a polymerase and nucleotide to form a stabilized ternary complex;

(ii) detecting the stabilized ternary complex to identify the nucleotide in the stabilized ternary complex;

(iii) extending the second primer to form a modified second hybrid on the nucleic acid; and

(iv) repeating (i), (ii) and (iii) for the modified second hybrid of the nucleic acid, thereby determining a sequence for at least a portion of the second template region.

2. The method of claim 1 , wherein (a) comprises

(i) hybridizing the first primer to the template region of the nucleic acid to form a first primer template hybrid;

(ii) binding the first hybrid to a polymerase and nucleotide to form a stabilized ternary complex;

(iii) detecting the stabilized ternary complex to identify the nucleotide in the stabilized ternary complex;

(iv) extending the first primer along the first template region of the nucleic acid to form a modified first hybrid on the nucleic acid; and

(v) repeating (ii), (iii) and (iv) for the modified first hybrid of the nucleic acid, thereby determining the sequence for the portion of the first template region.

3. The method of claim 2 , wherein (a)(v) comprises repeating (ii), (iii) and (iv) at least 10 times for the modified first hybrid of the nucleic acid, thereby determining the sequence for the portion of the first template.

4. The method of claim 1 , wherein (a) comprises extending the first primer along the first template region in a sequencing by synthesis process.

5. The method of claim 1 , wherein (d)(iv) comprises repeating (i), (ii) and (iii) at least 10 times for the modified second hybrid of the nucleic acid, thereby determining the sequence for the portion of the second template.

6. The method of claim 1 , wherein the capping of the extended primer comprises incorporating a nucleotide comprising a ligand and then binding the ligand to a receptor to form the ternary complex inhibitor moiety.

7. The method of claim 1 , wherein (a) comprises a sequencing by binding process.

8. The method of claim 1 , wherein (a) comprises extending the first primer along the first template region in a sequencing by ligation process.

9. The method of claim 1 , wherein the ternary complex inhibitor moiety is present at a 3′ end of the extended first primer.

10. The method of claim 9 , wherein the ternary complex inhibitor moiety creates a steric block to one or more components that would otherwise form a ternary complex.

11. The method of claim 9 , wherein the ternary complex inhibitor moiety provides a charge that repels one or more components that would otherwise form a ternary complex.

12. The method of claim 9 , wherein step (b) comprises incorporating a nucleotide analog that comprises the ternary complex inhibitor moiety into the extended first primer.

13. The method of claim 12 , wherein the nucleotide analog prevents nucleotide incorporation at the 3′-end of the extended first primer.

14. The method of claim 9 , wherein the ternary complex inhibitor moiety of step (b) is of a non-incorporable nucleotide analog.

15. The method of claim 1 , wherein step (d)(iii) of extending comprises incorporating a reversibly terminated nucleotide.

16. The method of claim 15 , wherein step (d)(iv) of repeating further comprises cleaving a reversible terminator from the extended primer between step (ii) of detecting and step (iii) of extending.

17. The method of claim 2 , wherein step (a)(iv) of extending comprises incorporating a reversibly terminated nucleotide.

18. The method of claim 15 , wherein step (d)(iv) of repeating further comprises cleaving a reversible terminator from the extended primer between step (ii) of detecting and step (iii) of extending.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2022
From: OMNIOME, LLC
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 059278/0153 →
MERGER Recorded Feb 2, 2022
From: OMNIOME, INC.
To: OMNIOME, LLC
Reel/Frame 058952/0352 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 10, 2021
From: SUBRAMANIAN, HARI K.K.; FLEISCHER, CHAD; MALYSHEV, DENIS
To: OMNIOME, INC.
Reel/Frame 058074/0226 →
Continuity (4)
Continuation 16657051 · Oct 18, 2019
Continuation In Part 16383279 · Apr 12, 2019
Provisional Application 62678434 · May 31, 2018
Related Publication 20220106628A1 · Apr 7, 2022